News

NEWS

LATEST NEWS

Patients with lymphoma or myeloma completed were assessed prior to and 1 month after initiating chemotherapy for depressive symptoms.

Depressive Symptoms May Be Associated With Survival in Patients With Hematologic Malignancies

Researchers assessed 266 pregnant women with and without sickle cell disease in Ghana.

Prevalence of Gastrointestinal Bleeding in Patients With von Willebrand Disease

Slow-Release Iron Treatment Appears Safe and Efficacious in Patients With Iron Deficiency Anemia

Continuing warfarin therapy for 18 months after an initial 6-month course decreased incidence of venous thrombosis and major bleeding.

Extended Oral Anticoagulation Therapy for First Unprovoked Deep Vein Thrombosis

Red blood cells macro over red eritrosit background.

Inhibitor Development Is Rare After 75 Days of Exposure to Factor VIII in Severe Hemophilia A

Image of chronic lymphocytic leukemia cells

Mode of Progression After Frontline Treatment Predicts Clinical Outcomes in Patients With CLL

Hospital Admission Rates in Children With Sickle Cell Disease Seeking Pain Management

UPCOMING MEETINGS

December 7 – 10, 2019
American Society of Hematology Annual Meeting and Exposition
Orlando, FL

Click here to view the full calendar

DRUG NEWS FROM MPR

Crizanlizumab Granted Priority Review for Sickle Cell Pain Crises Prevention

Dabigatran Safe, Effective for Managing VTE in Pediatric Trials

Rivaroxaban May Be Safe, Effective for Pediatric VTE Treatment, Says Study

FDA Approves Novel Therapy for Relapsed, Refractory Multiple Myeloma

Darzalex Gets Approval for Additional Multiple Myeloma Indication

Chemotherapy-Free Combo Therapy Approved for Previously Untreated CLL

Tibsovo Approved to Treat Newly Diagnosed AML With IDH1 Mutation

Novel Reversal Agent for Ticagrelor Gets FDA’s Breakthrough Tx Designation

FDA Places Clinical Hold on Venetoclax Trials for Multiple Myeloma

Esperoct Approval Provides New Treatment Option for Hemophilia A

Next hm-section-front in News

Meetings Calendar